1. Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure. DeBaun MR, Sarnaik SA, Rodeghier MJ, Minniti CP, Howard TH, Iyer RV, Inusa B, Telfer PT, Kirby-Allen M, Quinn CT, Bernaudin F, Airewele G, Woods GM, Panepinto JA, Fuh B, Kwiatkowski JK, King AA, Rhodes MM, Thompson AA, Heiny ME, Redding-Lallinger RC, Kirkham FJ, Sabio H, Gonzalez CE, Saccente SL, Kalinyak KA, Strouse JJ, Fixler JM, Gordon MO, Miller JP, Noetzel MJ, Ichord RN, Casella JF (2012) Blood 119(16): 3684-90
    › Citation · 22096242 (PubMed) · PMC3335377 (PubMed Central)
  2. A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. Milton JN, Sebastiani P, Solovieff N, Hartley SW, Bhatnagar P, Arking DE, Dworkis DA, Casella JF, Barron-Casella E, Bean CJ, Hooper WC, DeBaun MR, Garrett ME, Soldano K, Telen MJ, Ashley-Koch A, Gladwin MT, Baldwin CT, Steinberg MH, Klings ES (2012) PLoS One 7(4): e34741
    › Citation · 22558097 (PubMed) · PMC3338756 (PubMed Central)
  3. What is the evidence for using hydroxyurea for secondary stroke prevention? Lebensburger JD, DeBaun MR, Thompson AA (2011) Hematology Am Soc Hematol Educ Program : 440-2
    › Citation · 22160071 (PubMed)
  4. Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease. Hulbert ML, McKinstry RC, Lacey JL, Moran CJ, Panepinto JA, Thompson AA, Sarnaik SA, Woods GM, Casella JF, Inusa B, Howard J, Kirkham FJ, Anie KA, Mullin JE, Ichord R, Noetzel M, Yan Y, Rodeghier M, Debaun MR (2011) Blood 117(3): 772-9
    › Citation · 20940417 (PubMed) · PMC3035071 (PubMed Central)
  5. Secondary prevention of overt strokes in sickle cell disease: therapeutic strategies and efficacy. DeBaun MR (2011) Hematology Am Soc Hematol Educ Program : 427-33
    › Citation · 22160069 (PubMed)
  6. Recurrent, severe wheezing is associated with morbidity and mortality in adults with sickle cell disease. Cohen RT, Madadi A, Blinder MA, DeBaun MR, Strunk RC, Field JJ (2011) Am J Hematol 86(9): 756-61
    › Citation · 21809369 (PubMed) · PMC4103016 (PubMed Central)
  7. Plasma glial fibrillary acidic protein levels in children with sickle cell disease. Savage WJ, Barron-Casella E, Fu Z, Dulloor P, Williams L, Crain BJ, White DA, Jennings JM, Van Eyk JE, Debaun MR, Everett A, Casella JF (2011) Am J Hematol 86(5): 427-9
    › Citation · 21523806 (PubMed) · PMC3870012 (PubMed Central)
  8. Multi-modal intervention for the inpatient management of sickle cell pain significantly decreases the rate of acute chest syndrome. Reagan MM, DeBaun MR, Frei-Jones MJ (2011) Pediatr Blood Cancer 56(2): 262-6
    › Citation · 21157894 (PubMed) · PMC3057891 (PubMed Central)
  9. Genome-wide association study identifies genetic variants influencing F-cell levels in sickle-cell patients. Bhatnagar P, Purvis S, Barron-Casella E, DeBaun MR, Casella JF, Arking DE, Keefer JR (2011) J Hum Genet 56(4): 316-23
    › Citation · 21326311 (PubMed) · PMC5825003 (PubMed Central)
  10. Elevation of IgE in children with sickle cell disease is associated with doctor diagnosis of asthma and increased morbidity. An P, Barron-Casella EA, Strunk RC, Hamilton RG, Casella JF, DeBaun MR (2011) J Allergy Clin Immunol 127(6): 1440-6
    › Citation · 21388662 (PubMed) · PMC3105194 (PubMed Central)